22nd BioPharma Drug Discovery Nexus Conference

The 22nd BioPharma Drug Discovery Nexus Conference is scheduled for April 29–30, 2025, in the picturesque city of Brussels, Belgium. This esteemed event is meticulously curated to delve into the forefront of drug discovery, offering a comprehensive agenda that encompasses the latest trends and innovations in the field. Attendees will have the opportunity to explore a diverse range of topics, from the identification and validation of novel targets through human-centric AI to the revolutionary potential of cell and gene therapy. The conference aims to serve as a platform for invaluable insights, fostering collaborative discussions and breakthroughs that are poised to shape the future of medicine. The conference will feature presentations from distinguished speakers, including Tomasz Grabowski, Head of Preclinical Development at JJP Biologics; Richard Lewis, Director of Data Science and CADD at Novartis; and David Moreno Delgado, Associate Director of Assay Development and Technologies at Galapagos. These experts, among others, will share their knowledge and experiences, providing attendees with a comprehensive understanding of the current landscape and future directions in drug discovery. The event is designed to facilitate networking and collaboration among professionals from various sectors, including pharmaceutical and biotech industries, academia, and service providers, all united in their commitment to advancing healthcare innovation.